Investor Ideas #Potcasts
#Cannabis News and Stocks on the Move: (TSX: $ATD-A.TO; $ATD-B.TO) (TSX:
$WEED.TO) (NYSE: $CGC), (TSXV: $RTI.V) (OTCQX: $RDDTF), (TSX: $TGOD.TO) (OTC:
$TGODF)
Delta,
Kelowna, BC – February 22, 2019 (Investorideas.com Newswire)
www.Investorideas.com, a global news source covering leading sectors including
marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s edition of Investorideas.com potcastsCM - cannabis news and
stocks to watch plus insight from thought leaders and experts.
Listen
to the podcast:
Read
this in full at https://www.investorideas.com/news/2019/cannabis-potcasts/02221ATA-WEED-CGC-RTI-RDDTF-TGOD-TGODF.asp
Today’s
podcast overview/transcript:
Good afternoon and
welcome to another Investorideas.com “potcast”, looking at cannabis news,
stocks to watch as well as insights from thought leaders and experts.
Today we are
looking at announcements from Alimentation Couche-Tard Inc. (TSX: ATD.A) (TSX: ATD.B),Canopy Growth Corporation (TSX: WEED) (NYSE: CGC), Radient
Technologies Inc. (TSXV:RTI) (OTCQX:RDDTF) and The Green
Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF).
Alimentation
Couche-Tard Inc. announced that it has entered into a multi-year agreement with
Canopy Growth Corporation.
Subsequent to this
newly formed strategic partnership, and pending the results of a
public-consultation process, Alimentation Couche-Tard announce that it has
entered into a trademark license agreement with one of the winners of the
Alcohol and Gaming Commission of Ontario's (the "AGCO") Expression of
Interest Application Lottery, who will operate a "Tweed" branded
retail store in London, Ontario, once the process is complete. The lottery
winner will have full ownership and control over the London store.
Through this
partnership, Alimentation Couche-Tard is aiming to lean on Canopy Growth's
cannabis expertise and leverage its experience with other age-restricted
products to focus on the safe, responsible and lawful sale of cannabis, consistent
with the legislation enacted by the federal and provincial governments. As two
Canadian-made and globally-positioned companies, the London location will serve
as an important entry to market that could lead to future international
opportunities.
"Alimentation
Couche-Tard is excited about taking a leadership role in the development of
cannabis retailing excellence in this major Canadian market. We believe the
Ontario Cannabis Store and private retailers will co-exist under a tightly
regulated framework with common goals to protect public health and
safety," added Brian Hannasch.
Canopy Growth Corporation also
announced the appointment of Dr. Danial
Schecter as Director of
Global Medical Services. Dr. Schecter is widely recognized as an expert in the
clinical use of medical cannabis and will use his experience to expand the
Company's network of partner healthcare clinics and support doctors and
patients who understand the value of cannabis as medicine.
"I have had the honour of serving a range of patients
who, after exhausting traditional pharmaceutical approaches, have reported the
remarkable benefits of therapeutic cannabis," said Dr. Schecter. "As
Canopy Growth's new Director of Global Medical Services, it will be my
privilege to share the lessons learned from my vast clinical experience to
benefit new cohorts of physicians and patients, both nationally and globally,
who are able to access federally regulated medical cannabis."
Dr. Schecter's approach will rely on educational and
outreach activities, including establishing new mentorship opportunities,
developing training modules and organizing advisory boards that will assist
healthcare providers in each jurisdiction that allows medical cannabis access.
In addition, he will identify and support clinics partnered with Spectrum
Cannabis and ensure they operate at the highest standards.
Radient
Technologies Inc. announced that it has filed
an additional 17 provisional patent applications with the United States Patent
and Trademark Office . These applications cover inventions related to novel and
improved methods and systems of consuming cannabis extracts and
cannabis-infused products, in particular for medicinal cannabis consumers.
These filings bring the total number of patent applications filed by the Company
in 2018 and 2019 to 60, and mark the expansion of the Company’s intellectual
property in the consumer and medical sectors of the cannabis and hemp
industries.
In order to meet
the growing consumer demand for safe cannabinoid-infused products and devices
with an improved variety of delivery methods, the Patent Applications relate to
novel devices capable of accurately monitoring cannabis consumption, providing
relief from cannabis-induced side effects, and delivering cannabinoid extracts
via alternate pathways (e.g. nasal, oral mucosal, transdermal, etc.).
Several of these
inventions provide novel solutions which may reduce harm and discomfort
associated with existing methods of consuming cannabis products, specifically
for medicinal cannabis patients. For example, cannabis has traditionally been
consumed by smoking, which has negative effects on the respiratory system.
Alternatively, cannabis is often consumed orally, such as through the ingestion
of cannabis ‘edibles’, which are associated with a delayed onset and
bioavailability, as well as difficulties with controlling dosage. These
inventions could eliminate or reduce the risks associated with cannabinoid
dosage and delivery to create safer, standardized cannabinoid-infused products.
The Patent
Applications also disclose methods of improving the experience of cannabis
consumption for medicinal cannabis patients and consumers. These include
methods for allowing cannabis consumers to share experiences over social media,
testing methodologies for determining consumer preferences for product
selection, and monitoring user biometrics to suggest consumption schedules.
The Patent
Applications were first filed in the USPTO to create a priority date and allow
for future filings in other selected jurisdictions, as appropriate, including
Canada.
The Green Organic Dutchman Holdings Ltd. provided
an update on its Jamaican partner Epican Medicinals Ltd.
In June 2018, TGOD purchased 49.18% interest in Epican, a
fully integrated Jamaican cannabis company with cultivation, extraction,
manufacturing and retail distribution licenses.
Significant progress has been made towards expanding
cultivation, opening additional retail dispensaries, and establishing a
leadership position in Jamaica's robust medical cannabis market.
Jamaica has long been recognized as a premier location for
cannabis enthusiasts and Epican has deep roots in the country. Founders, the
McKenzie brothers, have been at the forefront of the nation's burgeoning
medical cannabis industry, including extensive advocacy for the responsible
development of the industry. Epican was awarded the country's historic first cultivation
license and continues to forge the path to serving the medical needs of the
country's 3 million inhabitants and nearly 4.3 million tourists each year.
"We have made incredible progress in Jamaica over the
past 8 months," commented Brian Athaide, Director and CEO of TGOD.
"We plan to continue opening stores throughout the country, increasing
productive capacity, and expanding our leadership in Jamaica. As Trelawny comes
online in phases, we will accelerate production to meet growing demand within
Jamaica and export product through TGOD's distribution channels in Mexico and
beyond."
The 49.18% Jamaican investment is an integral component of
TGOD's international strategy, together with distribution and operations in
Europe, Latin America and North America provide the Company with a strong
foundation to rapidly expand organic initiatives across the globe.
Investor ideas reminds all listeners to read our
disclaimers and disclosures on the
Investorideas.com website and this podcast is not
an endorsement to buy products or services or securities. Investors are
reminded all investment involves risk and possible loss of investment
Subscribe
to the new cannabis podcast series:
Investorideas.com podcasts
are also available on iTunes, Spotify,
Google Play Music, Stitcher, Spreaker,
YouTube via Spreaker, iHeartradio
and Tunein.
Potcasts
is now a certified word mark Trademark on the blockchain through Cognate, Inc.
CM Certification-Registration Number: 10468217708
Get the cannabis/hemp stock directory as an Investor ideas member , plus
get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the
Move. Learn more https://www.investorideas.com/membership/
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a
recognized news source publishing third party news and press releases plus we
create original financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts
and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto
Corner and Podcast, Play by Play sports and stock news column, Investor
Ideas #Potcasts #Cannabis News and Stocks on the Move
podcast and column, Cleantech and
Climate Change Podcast and the AI Eye Podcast and column covering
developments in AI.
Disclaimer/Disclosure:
Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Contact each company
directly regarding content and press release questions. Disclosure is posted
for each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers.
Learn more about Investor
ideas podcast and news publication
services and costs https://www.investorideas.com/News-Upload/
Additional info regarding
BC Residents and global Investors: Effective September 15 2008 - all BC
investors should review all OTC and Pink sheet listed companies for adherence
in new disclosure filings and filing appropriate documents with Sedar. Read for
more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Please read
Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does
not condone the use of cannabis except where permissible by law. Our site does
not possess, distribute, or sell cannabis products.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
